MIP-1 ALPHA RECEPTOR LIGANDS - DRUGS FOR T-CELL MEDIATED AND AUTOIMMUNE DISEASES

Details for Australian Patent Application No. 2002256585 (hide)

Owner CHEMOKINE THERAPEUTICS CORPORATION

Inventors TUDAN, Christopher, R.; SALARI, Hassan; SAXENA, Geeta

Pub. Number AU-A-2002256585

PCT Pub. Number WO2002/094270

Priority 60/291,818 18.05.01 US; 09/993,354 13.11.01 US

Filing date 16 May 2002

Wipo publication date 3 December 2002

International Classifications

A61K 031/475 - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 037/00 Drugs for immunological or allergic disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002256585

4 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002256586-METHOD AND SYSTEM FOR DISPLAYING ANALYTICS ABOUT A WEBSITE AND ITS CONTENTS

2002256584